Neldazosin

CAS No. 109713-79-3

Neldazosin( —— )

Catalog No. M35569 CAS No. 109713-79-3

Neldazosin is used as a potent α1-adrenoceptor antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 315 In Stock
5MG 302 In Stock
10MG 437 In Stock
25MG 673 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Neldazosin
  • Note
    Research use only, not for human use.
  • Brief Description
    Neldazosin is used as a potent α1-adrenoceptor antagonist.
  • Description
    Neldazosin is a potent alpha1-adrenoceptor antagonist.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Adrenergic Receptor
  • Recptor
    Adrenergic Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    109713-79-3
  • Formula Weight
    375.42
  • Molecular Formula
    C18H25N5O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    NC=1C2=C(N=C(N1)N3CCN(C(CC(C)O)=O)CC3)C=C(OC)C(OC)=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Choi JI, et al. Time course for blood pressure lowering of alpha blockers. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD010083.
molnova catalog
related products
  • Silodosin

    A highly potent, uroselective α1a-adrenoceptor antagonist with Ki of 36 pM; displays 583- and 56-fold lower potency against α1b and α1d respectors, respectively.

  • BRL 37344 sodium

    BRL 37344 is a potent and selective β3 adrenoceptor agonist with Ki of 287 nM; has weaker binding affinity for β1 and β2 receptors with Ki of 1750 and 1120 nM, respectively.

  • Bedoradrine

    Bedoradrine (MN-221) free base is a novel, highly selective β2-adrenoceptor agonist for the treatment of asthma and chronic obstructive pulmonary disease.